ambisome liposomal innrennslisstofn, ördreifa 50 mg
gilead sciences ireland uc* - amphotericinum b inn - innrennslisstofn, ördreifa - 50 mg
zalmoxis
molmed spa - Ósamgena t-frumurnar erfðabreytt með retróveira vektor kóðun fyrir styttu mynd af mönnum lágt skyldleiki taug vöxt þáttur viðtaka (Δlngfr) og herpes simplex ég veira thymidine nt (herpes-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - Æxlishemjandi lyf - zalmoxis er fram eins og venjulega meðferð í haploidentical skurðaðgerðir stafa klefi ígræðslu (hsct) af fullorðnum sjúklinga með hár-hættu blóðfræðileg illkynja.
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - eitilfrumukrabbamein, mantle-cell - Æxlishemjandi lyf - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
azitromicina normon filmuhúðuð tafla 500 mg
laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
azithromycin stada filmuhúðuð tafla 500 mg
stada arzneimittel ag - azithromycinum mónóhýdrat - filmuhúðuð tafla - 500 mg
azithromycin stada mixtúruduft, dreifa 40 mg/ml
stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 7,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 7,5 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 20 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 20 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 25 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 25 mg
metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 17,5 mg
medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 17,5 mg